Oncology News
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Oncology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain Management/
    Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
brca1  brca1
prostate-specific antigen  prostate-specific antigen
sclc  sclc
fobt  fobt
egd  egd
bmi  bmi
dysplasia  dysplasia
hematologic  hematologic
ovarian  ovarian
hcc  hcc
 
Sponsor
MDLinx Email Article

To email this article, enter your own "From Email" address,
the recipient's "To Email" address, and click the "Send Email" button.
You may send to up to 5 email addresses.
*From Email:  
*To Email:  
To Email:  
To Email:  
To Email:  
To Email:  
Osteosarcoma of the jaw/craniofacial region
Guadagnolo BA et al. - In a study to evaluate outcomes in pts with osteosarcoma of the head and neck (OHN) who were treated with surgery with or without radiotherapy (RT), it was determined that RT in addition to surgery improves overall survival (OS), disease-specific survival (DSS), and local control (LC) for pts with OHN who have positive/uncertain resection margins.

Methods
  • 119 pts with OHN underwent macroscopic total resection with or without RT.
  • Median age of the pts was 33 yrs.
  • Of these 119 pts, 92 (77%) underwent surgery alone whereas 27 (23%) pts were treated with combined modality treatment (CMT) comprised of surgery and RT (median dose, 60 Gray [Gy]).

Results
  • Median follow-up was 5.8 yrs.
  • OS rates at 5 and 10 yrs were 63% and 55%, respectively.
  • Corresponding DSS rates were 67% and 61%, respectively.
  • Stratified analysis by resection margin status demonstrated that CMT compared with surgery alone improved OS (80% vs 31%) and DSS (80% vs 35%) for pts with positive/uncertain resection margins.
  • Multivariate analysis indicated that CMT for pts with positive/uncertain resection margins improved OS.
  • 44 (36.97%) pts experienced local disease recurrence (LR) and 25 (21%) developed distant metastases (DM).
  • There was no difference noted with regard to DSS if disease recurrence was isolated (LR vs DM: 26% vs 29%, respectively, at 5 yrs).
  • Use of CMT vs surgery alone improved local control (LC) (75% vs 24%) for pts with positive/uncertain resection margins.
  • Rate of surgical complications was 28% at 5 yrs.
  • Rates of RT-associated complications were 40% and 47% at 5 and 10 yrs, respectively.
[more...]
Sponsor

Read a Different Specialty

Oncology Articles
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Oncology Articles
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.